The Importance of the Gastrointestinal Tract in Controlling Food Intake and Regulating Energy Balance

Bauer, 2016, Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota, Cell Mol Life Sci, 73, 737, 10.1007/s00018-015-2083-z Dockray, 2013, Enteroendocrine cell signalling via the vagus nerve, Curr Opin Pharmacol, 13, 954, 10.1016/j.coph.2013.09.007 Dockray, 2014, Gastrointestinal hormones and the dialogue between gut and brain, J Physiol, 592, 2927, 10.1113/jphysiol.2014.270850 Pi-Sunyer, 2015, A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management, N Engl J Med, 373, 11, 10.1056/NEJMoa1411892 Davies, 2015, Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE Diabetes Randomized Clinical Trial, JAMA, 314, 687, 10.1001/jama.2015.9676 Shah, 2006, Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status, J Clin Endocrinol Metab, 91, 4223, 10.1210/jc.2006-0557 Finan, 2015, A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents, Nat Med, 21, 27, 10.1038/nm.3761 Gribble, 2016, Enteroendocrine cells: chemosensors in the intestinal epithelium, Annu Rev Physiol, 78, 277, 10.1146/annurev-physiol-021115-105439 Latorre, 2016, Enteroendocrine cells: a review of their role in brain-gut communication, Neurogastroenterol Motil, 28, 620, 10.1111/nmo.12754 Bohorquez, 2014, An enteroendocrine cell-enteric glia connection revealed by 3D electron microscopy, PLoS One, 9, e89881, 10.1371/journal.pone.0089881 Habib, 2013, Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells, Diabetologia, 56, 1413, 10.1007/s00125-013-2887-z Gibbs, 1973, Cholecystokinin decreases food intake in rats, J Comp Physiol Psychol, 84, 488, 10.1037/h0034870 Smith, 1985, Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats, Am J Physiol, 249, R638 Schwartz, 1991, Integration of vagal afferent responses to gastric loads and cholecystokinin in rats, Am J Physiol, 261, R64 Moran, 1998, Disordered food intake and obesity in rats lacking cholecystokinin A receptors, Am J Physiol, 274, R618 Beglinger, 2001, Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans, Am J Physiol Regul Integr Comp Physiol, 280, R1149, 10.1152/ajpregu.2001.280.4.R1149 Dufresne, 2006, Cholecystokinin and gastrin receptors, Physiol Rev, 86, 805, 10.1152/physrev.00014.2005 Kopin, 1999, The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight, J Clin Invest, 103, 383, 10.1172/JCI4901 Desai, 2016, Beneficial effects of beta-sitosterol on type 1 cholecystokinin receptor dysfunction induced by elevated membrane cholesterol, Clin Nutr, 35, 1374, 10.1016/j.clnu.2016.03.003 Holst, 2007, The physiology of glucagon-like peptide 1, Physiol Rev, 87, 1409, 10.1152/physrev.00034.2006 Herrmann, 1995, Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients, Digestion, 56, 117, 10.1159/000201231 Guedes, 2015, Detailed characterization of incretin cell distribution along the human small intestine, Surg Obes Relat Dis, 11, 1323, 10.1016/j.soard.2015.02.011 Calanna, 2013, Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies, Diabetes Care, 36, 3346, 10.2337/dc13-0465 Scrocchi, 1996, Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene, Nat Med, 2, 1254, 10.1038/nm1196-1254 Abbott, 2005, The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway, Brain Res, 1044, 127, 10.1016/j.brainres.2005.03.011 van Bloemendaal, 2014, GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans, Diabetes, 63, 4186, 10.2337/db14-0849 Yousseif, 2014, Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans, Obes Surg, 24, 241, 10.1007/s11695-013-1066-0 Pocai, 2014, Action and therapeutic potential of oxyntomodulin, Mol Metab, 3, 241, 10.1016/j.molmet.2013.12.001 Wewer Albrechtsen, 2016, The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs, BMC Res Notes, 9, 60, 10.1186/s13104-016-1872-2 Dakin, 2004, Peripheral oxyntomodulin reduces food intake and body weight gain in rats, Endocrinology, 145, 2687, 10.1210/en.2003-1338 Cohen, 2003, Oxyntomodulin suppresses appetite and reduces food intake in humans, J Clin Endocrinol Metab, 88, 4696, 10.1210/jc.2003-030421 Wynne, 2005, Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial, Diabetes, 54, 2390, 10.2337/diabetes.54.8.2390 Wynne, 2006, Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial, Int J Obes (Lond), 30, 1729, 10.1038/sj.ijo.0803344 Cegla, 2014, Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intake, Diabetes, 63, 3711, 10.2337/db14-0242 Parkinson, 2009, Differential patterns of neuronal activation in the brainstem and hypothalamus following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in mice detected by manganese-enhanced magnetic resonance imaging (MEMRI), Neuroimage, 44, 1022, 10.1016/j.neuroimage.2008.09.047 Price, 2015, Investigating the glucagon receptor and glucagon-like peptide 1 receptor activity of oxyntomodulin-like analogues in male Wistar rats, Curr Ther Res Clin Exp, 77, 111, 10.1016/j.curtheres.2015.10.003 Manning, 2014, The role of gut hormone peptide YY in energy and glucose homeostasis: twelve years on, Annu Rev Physiol, 76, 585, 10.1146/annurev-physiol-021113-170404 Batterham, 2002, Gut hormone PYY(3-36) physiologically inhibits food intake, Nature, 418, 650, 10.1038/nature00887 Batterham, 2006, Critical role for peptide YY in protein-mediated satiation and body-weight regulation, Cell Metab, 4, 223, 10.1016/j.cmet.2006.08.001 Batterham, 2007, PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans, Nature, 450, 106, 10.1038/nature06212 Ramracheya, 2016, PYY-Dependent restoration of impaired insulin and glucagon secretion in type 2 diabetes following Roux-en-Y gastric bypass surgery, Cell Rep, 15, 944, 10.1016/j.celrep.2016.03.091 Moyse, 1987, Distribution of neurotensin binding sites in rat brain: a light microscopic radioautographic study using monoiodo [125I]Tyr3-neurotensin, Neuroscience, 22, 525, 10.1016/0306-4522(87)90350-2 Sjolund, 1983, Endocrine cells in human intestine: an immunocytochemical study, Gastroenterology, 85, 1120, 10.1016/S0016-5085(83)80080-8 Remaury, 2002, Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia, Brain Res, 953, 63, 10.1016/S0006-8993(02)03271-7 Opland, 2013, Loss of neurotensin receptor-1 disrupts the control of the mesolimbic dopamine system by leptin and promotes hedonic feeding and obesity, Mol Metab, 2, 423, 10.1016/j.molmet.2013.07.008 Aronin, 1982, The stability and metabolism of intravenously administered neurotensin in the rat, Peptides, 3, 637, 10.1016/0196-9781(82)90164-4 Sandoval, 1992, Effects of peripheral neurotensin on behavior of the rat, Pharmacol Biochem Behav, 41, 385, 10.1016/0091-3057(92)90115-V Ratner, 2016, Effects of peripheral neurotensin on appetite regulation and its role in gastric bypass surgery, Endocrinology, 157, 3482, 10.1210/en.2016-1329 Grunddal, 2016, Neurotensin is coexpressed, coreleased, and acts together with GLP-1 and PYY in enteroendocrine control of metabolism, Endocrinology, 157, 176, 10.1210/en.2015-1600 Naslund, 1997, Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity, Int J Obes Relat Metab Disord, 21, 387, 10.1038/sj.ijo.0800418 Ye, 2016, Neurotensin, a novel messenger to cross-link inflammation and tumor invasion via epithelial-mesenchymal transition pathway, Int Rev Immunol, 35, 340 Kojima, 1999, Ghrelin is a growth-hormone-releasing acylated peptide from stomach, Nature, 402, 656, 10.1038/45230 Date, 2000, Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans, Endocrinology, 141, 4255, 10.1210/endo.141.11.7757 Muller, 2015, Ghrelin, Mol Metab, 4, 437, 10.1016/j.molmet.2015.03.005 Cummings, 2001, A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans, Diabetes, 50, 1714, 10.2337/diabetes.50.8.1714 Callahan, 2004, Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans, J Clin Endocrinol Metab, 89, 1319, 10.1210/jc.2003-031267 Yang, 2008, Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone, Cell, 132, 387, 10.1016/j.cell.2008.01.017 Druce, 2005, Ghrelin increases food intake in obese as well as lean subjects, Int J Obes (Lond), 29, 1130, 10.1038/sj.ijo.0803001 Ashby, 2009, Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment, Kidney Int, 76, 199, 10.1038/ki.2009.114 Sun, 2004, Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor, Proc Natl Acad Sci U S A, 101, 4679, 10.1073/pnas.0305930101 Cowley, 2003, The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis, Neuron, 37, 649, 10.1016/S0896-6273(03)00063-1 Arnold, 2006, Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat, J Neurosci, 26, 11052, 10.1523/JNEUROSCI.2606-06.2006 Kouno, 2016, Reduced intake of carbohydrate prevents the development of obesity and impaired glucose metabolism in ghrelin O-acyltransferase knockout mice, Peptides, 86, 145, 10.1016/j.peptides.2016.11.003 Wortley, 2005, Absence of ghrelin protects against early-onset obesity, J Clin Invest, 115, 3573, 10.1172/JCI26003 Karra, 2013, A link between FTO, ghrelin, and impaired brain food-cue responsivity, J Clin Invest, 123, 3539, 10.1172/JCI44403 Cummings, 2002, Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery, N Engl J Med, 346, 1623, 10.1056/NEJMoa012908 Goldstone, 2004, Elevated fasting plasma ghrelin in prader-willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance, J Clin Endocrinol Metab, 89, 1718, 10.1210/jc.2003-031118 Temel, 2016, Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials, Lancet Oncol, 17, 519, 10.1016/S1470-2045(15)00558-6 Hosoda, 2000, Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue, Biochem Biophys Res Commun, 279, 909, 10.1006/bbrc.2000.4039 Kuppens, 2015, Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome, Endocrine, 50, 633, 10.1007/s12020-015-0614-x Andrade, 2013, Immunization against active ghrelin using virus-like particles for obesity treatment, Curr Pharm Des, 19, 6551, 10.2174/13816128113199990506 Monteiro, 2014, Obesity vaccines, Hum Vaccin Immunother, 10, 887, 10.4161/hv.27537 Oh, 2006, Identification of nesfatin-1 as a satiety molecule in the hypothalamus, Nature, 443, 709, 10.1038/nature05162 Stengel, 2015, Nesfatin-1—more than a food intake regulatory peptide, Peptides, 72, 175, 10.1016/j.peptides.2015.06.002 Stengel, 2013, The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors, Obes Rev, 14, 859, 10.1111/obr.12063 Dore, 2017, Nesfatin-1: functions and physiology of a novel regulatory peptide, J Endocrinol, 232, R45, 10.1530/JOE-16-0361 Bado, 1998, The stomach is a source of leptin, Nature, 394, 790, 10.1038/29547 Cammisotto, 2012, A review on gastric leptin: the exocrine secretion of a gastric hormone, Anat Cell Biol, 45, 1, 10.5115/acb.2012.45.1.1 Sobhani, 2002, Vagal stimulation rapidly increases leptin secretion in human stomach, Gastroenterology, 122, 259, 10.1053/gast.2002.31385 Kentish, 2013, Gastric vagal afferent modulation by leptin is influenced by food intake status, J Physiol, 591, 1921, 10.1113/jphysiol.2012.247577 Spreckley, 2015, The L-cell in nutritional sensing and the regulation of appetite, Front Nutr, 2, 23, 10.3389/fnut.2015.00023 Panaro, 2014, The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo, Cell Metab, 20, 1018, 10.1016/j.cmet.2014.10.004 Brighton, 2015, Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors, Endocrinology, 156, 3961, 10.1210/en.2015-1321 Batterham, 2016, Mechanisms of diabetes improvement following bariatric/metabolic surgery, Diabetes Care, 39, 893, 10.2337/dc16-0145 Schouten, 2010, A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery, Ann Surg, 251, 236, 10.1097/SLA.0b013e3181bdfbff Rajagopalan, 2016, Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study, Diabetes Care, 39, 2254, 10.2337/dc16-0383 Janssen, 2011, Bitter taste receptors and alpha-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying, Proc Natl Acad Sci U S A, 108, 2094, 10.1073/pnas.1011508108 Rozengurt, 2006, Colocalization of the alpha-subunit of gustducin with PYY and GLP-1 in L cells of human colon, Am J Physiol Gastrointest Liver Physiol, 291, G792, 10.1152/ajpgi.00074.2006 Jang, 2007, Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1, Proc Natl Acad Sci U S A, 104, 15069, 10.1073/pnas.0706890104 Shin, 2008, Modulation of taste sensitivity by GLP-1 signaling, J Neurochem, 106, 455, 10.1111/j.1471-4159.2008.05397.x Martin, 2009, Modulation of taste sensitivity by GLP-1 signaling in taste buds, Ann N Y Acad Sci, 1170, 98, 10.1111/j.1749-6632.2009.03920.x Zolotukhin, 2013, Metabolic hormones in saliva: origins and functions, Oral Dis, 19, 219, 10.1111/odi.12015 Fujita, 2009, Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo, Am J Physiol Endocrinol Metab, 296, E473, 10.1152/ajpendo.90636.2008 Psichas, 2015, Gut chemosensing mechanisms, J Clin Invest, 125, 908, 10.1172/JCI76309 Wang, 2015, Apolipoprotein A-IV: a protein intimately involved in metabolism, J Lipid Res, 56, 1403, 10.1194/jlr.R052753 Fujimoto, 1992, Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation, Am J Physiol, 262, G1002 Kohan, 2015, ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety, Am J Physiol Gastrointest Liver Physiol, 308, G472, 10.1152/ajpgi.00098.2014 Currie, 1992, Guanylin: an endogenous activator of intestinal guanylate cyclase, Proc Natl Acad Sci U S A, 89, 947, 10.1073/pnas.89.3.947 Hamra, 1993, Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase, Proc Natl Acad Sci U S A, 90, 10464, 10.1073/pnas.90.22.10464 Brenna, 2016, Cellular localization of guanylin and uroguanylin mRNAs in human and rat duodenal and colonic mucosa, Cell Tissue Res, 365, 331, 10.1007/s00441-016-2393-y Folgueira, 2016, Uroguanylin levels in intestine and plasma are regulated by nutritional status in a leptin-dependent manner, Eur J Nutr, 55, 529, 10.1007/s00394-015-0869-2 Valentino, 2011, A uroguanylin-GUCY2C endocrine axis regulates feeding in mice, J Clin Invest, 121, 3578, 10.1172/JCI57925 Begg, 2014, Effect of guanylate cyclase-C activity on energy and glucose homeostasis, Diabetes, 63, 3798, 10.2337/db14-0160 Rodriguez, 2016, Guanylin and uroguanylin stimulate lipolysis in human visceral adipocytes, Int J Obes (Lond), 40, 1405, 10.1038/ijo.2016.66 DiPatrizio, 2016, Endocannabinoids in the Gut, Cannabis Cannabinoid Res, 1, 67, 10.1089/can.2016.0001 DiPatrizio, 2015, Intestinal lipid-derived signals that sense dietary fat, J Clin Invest, 125, 891, 10.1172/JCI76302 Besnard, 2016, Taste of fat: a sixth taste modality?, Physiol Rev, 96, 151, 10.1152/physrev.00002.2015 Fu, 2003, Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha, Nature, 425, 90, 10.1038/nature01921 Rodriguez de Fonseca, 2001, An anorexic lipid mediator regulated by feeding, Nature, 414, 209, 10.1038/35102582 Azari, 2014, Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide, Am J Physiol Regul Integr Comp Physiol, 307, R167, 10.1152/ajpregu.00067.2014 Sclafani, 2013, Gut-brain nutrient signaling. Appetition vs. satiation, Appetite, 71, 454, 10.1016/j.appet.2012.05.024 Sclafani, 2016, SGLT1 sugar transporter/sensor is required for post-oral glucose appetition, Am J Physiol Regul Integr Comp Physiol, 310, R631, 10.1152/ajpregu.00432.2015 Han, 2016, Striatal dopamine links gastrointestinal rerouting to altered sweet appetite, Cell Metab, 23, 103, 10.1016/j.cmet.2015.10.009 Sclafani, 2013, GPR40 and GPR120 fatty acid sensors are critical for postoral but not oral mediation of fat preferences in the mouse, Am J Physiol Regul Integr Comp Physiol, 305, R1490, 10.1152/ajpregu.00440.2013 Finan, 2013, Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans, Sci Transl Med, 5, 209ra151, 10.1126/scitranslmed.3007218